evidencegaps
Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

116 questions · 117 findings · 23 reviews

Sort:Best matchNewestHighest certaintyDownload CSV
No studies found 38 · 32.5%GRADE not reported 2 · 1.7%Very low 49 · 41.9%Low 13 · 11.1%Moderate 15 · 12.8%High 0 · 0%

Therapeutic swallowing exercises vs treatment

Adverse event: Weight loss (> 10%) Change in nutritional status reflected by a patient's weight at 6 weeks after treatment · adults with advanced head and neck cancer

It is very uncertain whether therapeutic swallowing exercises changes adverse event: Weight loss (> 10%) Change in nutritional status… compared with treatment (very low certainty).

2 findings from 1 review

Therapeutic swallowing exercises vs sham

Adverse event: Weight loss (> 10%) Change in nutritional status reflected by a patient's weight at 6 weeks after treatment · adults with advanced head and neck cancer

It is very uncertain whether therapeutic swallowing exercises changes adverse event: Weight loss (> 10%) Change in nutritional status… compared with sham intervention (very low certainty).

1 finding from 1 review

Intervention not reported

Impaired function Unable to carry heavy weights or > 10° loss in extension (discomfort when carrying objects) At 12 months · patients being treated for radial head fractures; subsequent management was non‐surgical

It is very uncertain whether the intervention changes impaired function Unable to carry heavy weights or > 10° loss in… (very low certainty).

1 finding from 1 review

SWITCHING ‐ NEW ANTIPSYCHOTIC REGIMEN vs CONTINUATION ON PREVIOUS REGIMEN: 1b. NEW ATYPICAL from OLANZAPINE ‐ medium term (3‐12 months)

Satisfaction with care: Loss to · patients with people with schizophrenia who have neuroleptic‐induced weight or metabolic problems

It is very uncertain whether SWITCHING ‐ NEW ANTIPSYCHOTIC REGIMEN changes satisfaction with care: Loss to compared with CONTINUATION ON PREVIOUS REGIMEN: 1b. NEW ATYPICAL from OLANZAPINE ‐… (very low certainty).

1 finding from 1 review

SWITCHING ‐ NEW ANTIPSYCHOTIC REGIMEN vs CONTINUATION ON PREVIOUS REGIMEN: 1a. DIFFERENT DEPOT from DEPOT‐medium term (3‐12 months)

Satisfaction with care: Loss to · patients with people with schizophrenia who have neuroleptic‐induced weight or metabolic problems

It is very uncertain whether SWITCHING ‐ NEW ANTIPSYCHOTIC REGIMEN changes satisfaction with care: Loss to compared with CONTINUATION ON PREVIOUS REGIMEN: 1a. DIFFERENT DEPOT from… (very low certainty).

1 finding from 1 review